3 Disruptive Medical Innovations You Can Invest In
3-D-printed organs, needle-free injectors, and inhalable insulin -- these three disruptive medical innovations that are being brought to the market respectively by Organovo, Antares Pharma, and MannKind.
5 Potential FDA Approvals That May Change Millions of Lives in 2014
These five experimental therapies, if approved, could result in improved quality of life for millions of Americans in 2014.
4 Companies Completely Changing the Way We Treat Diabetes
Novo Nordisk, Eli Lilly, MannKind, and Medtronic are changing how we treat diabetes with better insulin, newer drugs, and wearable medical devices. Let’s take a look at their greatest accomplishments.
Novo Nordisk's Biggest Strength and Weakness
Is Novo Nordisk's (NYSE: NVO) diabetes treatment-focused strategy wise, or should the company diversify?